These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 3334580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS, Cocchetto DM.
    Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Ceftazidime in the treatment of infections in intensive care. Experience with 20 clinical cases].
    Liverta E, Pasquetti G, Carnevali M, Bellucci MC.
    Minerva Anestesiol; 1986; 52(1-2):47-9. PubMed ID: 3526183
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Empiric monotherapy in neutropenia: a realistic goal?
    Del Favero A, Bucaneve G, Menichetti F.
    Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
    [Abstract] [Full Text] [Related]

  • 9. Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
    Mészáros J, Tołłoczko T, Stachlewska E, Tyc Z, Jeljaszewicz J.
    J Chemother; 1989 Jul; 1(4 Suppl):828-9. PubMed ID: 16312658
    [No Abstract] [Full Text] [Related]

  • 10. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece.
    Ntagiopoulos PG, Paramythiotou E, Antoniadou A, Giamarellou H, Karabinis A.
    Int J Antimicrob Agents; 2007 Oct; 30(4):360-5. PubMed ID: 17629680
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime as monotherapy for fever and neutropenia: experience in a community hospital.
    Bizette GA, Brooks BJ, Alvarez S.
    J La State Med Soc; 1994 Oct; 146(10):448-52. PubMed ID: 7798779
    [Abstract] [Full Text] [Related]

  • 12. Ceftazidime (Fortaz).
    Med Lett Drugs Ther; 1985 Oct 11; 27(698):85-7. PubMed ID: 3900663
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of 42 patients treated with ceftazidime].
    Farci G, Laconi R, Lai ME, Balestrieri A.
    Clin Ter; 1985 Nov 15; 115(3):169-72. PubMed ID: 3910330
    [No Abstract] [Full Text] [Related]

  • 14. Aztreonam in the therapy of severe gram-negative infections.
    Davies A, Stone J, Hassan A, Quarty P, Green T.
    Chemioterapia; 1987 Jun 15; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract] [Full Text] [Related]

  • 15. Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
    Gasparini G, Benedetti M, Fassio T, Canobbio L, Figoli F, Galligioni E, Talamini R, Toffoli G, Tumolo S.
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb 15; 25(2):113-20. PubMed ID: 3549581
    [Abstract] [Full Text] [Related]

  • 16. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L, Jiménez A, Palmero S, Jiménez JJ, Iribarren JL, Santana M, Martín MM, Mora ML.
    Clin Ther; 2007 Nov 15; 29(11):2433-9. PubMed ID: 18158083
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of ceftazidime in the treatment of severe localized and systemic infections.
    Gabrielli GB, Corrocher R, De Sandre G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 15; 22(3):167-9. PubMed ID: 6370875
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study.
    Wunderlich CA, Krach LE.
    Dev Med Child Neurol; 2006 Jun 15; 48(6):450-5. PubMed ID: 16700935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.